BIOtechNow

New Report Shows Value of Quality Measures for Adult Vaccines


Listen Later

Every year, more than 40,000 American adults are hospitalized or die due to vaccine-preventable diseases. Treating vaccine-preventable diseases among adults also costs the U.S. tens of billions of dollar every year. As the U.S. population ages at an unprecedented rate, with 78 million Baby Boomers becoming seniors, improving rates of adult vaccination is a national imperative. In a new white paper, The Value and Imperative of Quality Measures for Adult Vaccines, renowned vaccine experts — Read More 
...more
View all episodesView all episodes
Download on the App Store

BIOtechNowBy Biotechnology Industry Organization